mRNA Technology - Search News

FDA refuses review of mRNA flu vaccine

FDA won’t consider a new mRNA vaccine for flu, despite the technology’s life-saving promise

The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

· 5h

FDA Refuses to Review Moderna's mRNA Flu Shot

· 1d · on MSN

FDA won’t review Moderna application for first mRNA-based flu vaccine

· 1d

FDA declines to review Moderna's mRNA flu shot

The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday.

· 21h

F.D.A. Refuses to Review Moderna Flu Vaccine

· 18h

Moderna shares fall as FDA declines to review new flu vaccine

· 1d

FDA refuses to review Moderna's influenza vaccine application

In its refusal-to-file letter, the FDA said ‌Moderna's choice to compare mRNA-1010 to an already licensed standard-dose seasonal influenza was the sole reason for the refusal to initiate a review of ...

· 1d

FDA refuses to review Moderna’s application for mRNA flu vaccine, company says

· 1d

Moderna says FDA refuses its application for new mRNA flu vaccine

Fierce Biotech

Sanofi abandons attempt to develop next-gen mRNA seasonal flu vaccine

Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.

12h

FDA refuses Moderna's application for new mRNA flu vaccine

The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.